Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer

Clinical trial NCT04940325 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04940325
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Lung Cancer Advanced Non Small Cell Lung Cancer Unresectable Non-small Lung Cancer

Start date: 2021-05-12
Primary completion: 2028-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.